Robert D. Casale
Robert D. Casale is a pharmaceutical industry veteran and currently serves as a Director on several Boards, including the Board of Directors for First Aid Shot Therapy, Novalere, and Insight Pharmaceuticals. Previously, Bob served as a Director for NextWave Pharmaceuticals, and he was Chairman of the Board of Directors for Topaz Pharmaceuticals, Inc.
Bob also co-founded Scerene Healthcare, Inc., in 2009 and served as its Chief Executive Officer. Prior to that, Bob served as COO of Adams Respiratory Therapeutics Inc., since October 2006. Bob served as Chief Development Officer, Chief Marketing Officer and Executive Vice President of Adams Respiratory Therapeutics from May 2005 to October 2006. Previously, Bob was Vice President, Business Development and Strategic Planning, for Pfizer, Inc., and he led development of a strategic plan for the newly merged Pfizer and Warner-Lambert consumer businesses.
Beginning in 1986, Bob served in many capacities at the former Warner-Lambert Company. Bob began his career at Warner-Lambert in their legal division, and later became lead counsel for Parke-Davis, the company's pharmaceutical business. He also served as lead counsel for the parent company on all acquisitions, merger, and licensing transactions. Subsequently, he was appointed Warner-Lambert's vice president of marketing for upper respiratory and gastrointestinal (GI) consumer products, including Benadryl®, Sudafed®, Zantac 75®, and Rolaids®. Bob also served as a Global Vice President for Warner-Lambert's GI and skin care businesses.
Bob received a bachelor's degree in business administration and English from Rutgers College in 1980 and a juris doctorate, with honors, from the Rutgers Law School in 1983.